1. From the Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the2Departments of Ophthalmology and3Pharmacology, David Geffen School of Medicine at the University of California, Los Angeles, California; the
2. From the Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the2Departments of Ophthalmology and4Ophthalmology Section, Greater Los Angeles VA Healthcare System, Los Angeles, California; and the
3. From the Ocular Inflammatory Disease Center, Jules Stein Eye Institute and the2Departments of Ophthalmology and
4. Department of Oral Molecular Biology, Oregon Health and Science University, Portland, Oregon.